John Frederick Ek - Mar 1, 2025 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
CFO
Signature
/s/ John Frederick Ek, by Brian McKelligon, as Attorney-in-Fact
Stock symbol
AKYA
Transactions as of
Mar 1, 2025
Transactions value $
-$5,858
Form type
4
Date filed
3/4/2025, 05:12 PM
Previous filing
Nov 21, 2024
Next filing
Apr 3, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Tax liability -$5.86K -3.59K -1.34% $1.63 265K Mar 1, 2025 Direct F1
holding AKYA Common Stock 20K Mar 1, 2025 Ek Trust Dated November 20, 2020
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to cover taxes on a restricted stock unit award previously granted on February 22, 2024, which vests in four (4) annual equal installments beginning on March 1, 2025 and annually thereafter until fully vested.